Review



nheks  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC nheks
    Nheks, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 388 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nheks/product/ATCC
    Average 99 stars, based on 388 article reviews
    nheks - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    nheks  (ATCC)
    99
    ATCC nheks
    Nheks, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nheks/product/ATCC
    Average 99 stars, based on 1 article reviews
    nheks - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    PromoCell primary heks
    Primary Heks, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary heks/product/PromoCell
    Average 96 stars, based on 1 article reviews
    primary heks - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    93
    Cell Applications Inc primary normal human epidermal kcs nheks
    Primary Normal Human Epidermal Kcs Nheks, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary normal human epidermal kcs nheks/product/Cell Applications Inc
    Average 93 stars, based on 1 article reviews
    primary normal human epidermal kcs nheks - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    99
    ATCC primary nheks
    ( A ) Representative images of murine wounds 7 days after infection with indicated S . aureus mutants. ( B ) Bacteria recovered from day 7 murine wounds infected with S . aureus mutants. ( C ) Quantification of closure on day 7 of murine wounds infected with S . aureus mutants. ( D ) LDH release from scratch-wounded <t>primary</t> <t>NHEKs</t> 24 hours after treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( E ) Scratch-wounded NHEK migration after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( F ) Proliferation measured with MTT assay of NHEKs after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( G ) KI67 gene expression in proliferating NHEKs treated for 24 hours with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). One-way ANOVA followed by Bonferroni’s multiple-comparison adjustment for more than 2 groups ( B – G ). Experiments were performed at least twice. Data represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Primary Nheks, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary nheks/product/ATCC
    Average 99 stars, based on 1 article reviews
    primary nheks - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    PromoCell primary normal human epidermal keratinocytes
    ( A ) Representative images of murine wounds 7 days after infection with indicated S . aureus mutants. ( B ) Bacteria recovered from day 7 murine wounds infected with S . aureus mutants. ( C ) Quantification of closure on day 7 of murine wounds infected with S . aureus mutants. ( D ) LDH release from scratch-wounded <t>primary</t> <t>NHEKs</t> 24 hours after treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( E ) Scratch-wounded NHEK migration after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( F ) Proliferation measured with MTT assay of NHEKs after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( G ) KI67 gene expression in proliferating NHEKs treated for 24 hours with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). One-way ANOVA followed by Bonferroni’s multiple-comparison adjustment for more than 2 groups ( B – G ). Experiments were performed at least twice. Data represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Primary Normal Human Epidermal Keratinocytes, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary normal human epidermal keratinocytes/product/PromoCell
    Average 96 stars, based on 1 article reviews
    primary normal human epidermal keratinocytes - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Lonza primary human keratinocyte cell line nhek-ad cells
    ( A ) Representative images of murine wounds 7 days after infection with indicated S . aureus mutants. ( B ) Bacteria recovered from day 7 murine wounds infected with S . aureus mutants. ( C ) Quantification of closure on day 7 of murine wounds infected with S . aureus mutants. ( D ) LDH release from scratch-wounded <t>primary</t> <t>NHEKs</t> 24 hours after treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( E ) Scratch-wounded NHEK migration after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( F ) Proliferation measured with MTT assay of NHEKs after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( G ) KI67 gene expression in proliferating NHEKs treated for 24 hours with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). One-way ANOVA followed by Bonferroni’s multiple-comparison adjustment for more than 2 groups ( B – G ). Experiments were performed at least twice. Data represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Primary Human Keratinocyte Cell Line Nhek Ad Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human keratinocyte cell line nhek-ad cells/product/Lonza
    Average 90 stars, based on 1 article reviews
    primary human keratinocyte cell line nhek-ad cells - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Representative images of murine wounds 7 days after infection with indicated S . aureus mutants. ( B ) Bacteria recovered from day 7 murine wounds infected with S . aureus mutants. ( C ) Quantification of closure on day 7 of murine wounds infected with S . aureus mutants. ( D ) LDH release from scratch-wounded primary NHEKs 24 hours after treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( E ) Scratch-wounded NHEK migration after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( F ) Proliferation measured with MTT assay of NHEKs after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( G ) KI67 gene expression in proliferating NHEKs treated for 24 hours with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). One-way ANOVA followed by Bonferroni’s multiple-comparison adjustment for more than 2 groups ( B – G ). Experiments were performed at least twice. Data represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: The Journal of Clinical Investigation

    Article Title: Staphylococcus aureus accessory gene regulator quorum-sensing system inhibits keratinocyte lipid enzymes and delays wound repair

    doi: 10.1172/JCI190411

    Figure Lengend Snippet: ( A ) Representative images of murine wounds 7 days after infection with indicated S . aureus mutants. ( B ) Bacteria recovered from day 7 murine wounds infected with S . aureus mutants. ( C ) Quantification of closure on day 7 of murine wounds infected with S . aureus mutants. ( D ) LDH release from scratch-wounded primary NHEKs 24 hours after treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( E ) Scratch-wounded NHEK migration after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( F ) Proliferation measured with MTT assay of NHEKs after 24-hour treatment with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). ( G ) KI67 gene expression in proliferating NHEKs treated for 24 hours with CM of S . aureus mutants (3 × 10 7 CFU/mL equivalent). One-way ANOVA followed by Bonferroni’s multiple-comparison adjustment for more than 2 groups ( B – G ). Experiments were performed at least twice. Data represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: Primary NHEKs (ATCC, PCS-200-010) were cultured in EpiLife medium containing 60 μM CaCl 2 (Gibco, MEPI500CA) supplemented with Human Keratinocyte Growth Supplement (Gibco, S0015) and antibiotic-antimycotic (penicillin 100 U/mL, streptomycin 100 U/mL, and amphotericin B 250 ng/mL; Gibco, 15240062) at 37°C, 5% CO 2 .

    Techniques: Infection, Bacteria, Migration, MTT Assay, Gene Expression, Comparison